Please assess the completion status of the following clinical trial:

Trial Title: Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-60 years, male or female~* DSM-IV criteria for schizophrenia~* Clozapine treatment~* At least 2 scores on the Nocturnal Hypersalivation Rating Scale (NHRS)~Exclusion Criteria:~* Evidence of organic brain damage, mental retardation, alcohol or drug abuse

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Moclobemide, (Type: ACTIVE_COMPARATOR): treatment during 2 weeks
- Amisulpride (Type: ACTIVE_COMPARATOR): Comparison

Based on this trial design, predict the completion outcome and termination type (if applicable).